Evidence map›Paper›PMID 21860259›Full record

ArticleHuman vaccines2011

Anti-angiogenesis immunotherapy.

Jonathan D Schoenfeld, Glenn Dranoff

Open access · bronzeAbstract read
In one paragraph

Article in Human vaccines, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Trimming the Vascular Tree in Tumors: Metabolic and Immune Adaptations.Cold Spring Harbor symposia on quantitative biology · 2016
    Review
  7. Review
  8. Angiogenic cytokines are antibody targets during graft-versus-leukemia reactions.Clinical cancer research : an official journal of the American Association for Cancer Research · 2015
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Jonathan D SchoenfeldHarvard Radiation Oncology Program and Harvard Medical School, Boston, MA, USA.
Glenn Dranoff
Brigham and Women's Hospital · USHarvard University · US

Funding

Targeting Myeloma Cell-Host Bone Marrow InteractionsP01CA078378 · NCI · DANA-FARBER CANCER INSTITUTE · PI KUFE, DONALD W. · 1998 to 2014
$26.2M
Reconstitution of Regulatory T Cells after Allogeneic Stem Cell TransplantationU19AI029530 · NIAID · DANA-FARBER CANCER INSTITUTE · PI SOIFFER, ROBERT JON · 2005 to 2010
$9.0M
T CELL NEOGENESIS AFTER STEM CELL TRANSPLANTATIONP01AI029530 · NIAID · DANA-FARBER CANCER INSTITUTE · PI RITZ, JEROME · 1990 to 2003
$4.5M
Targeting MFG-E8 as Melanoma ImmunotherapyR01CA143083 · NCI · DANA-FARBER CANCER INST · PI DRANOFF, GLENN · 2010 to 2014
$1.6M
Targets of Immune-Mediated Tumor DestructionR01CA111506 · NCI · DANA-FARBER CANCER INSTITUTE · PI DRANOFF, GLENN · 2005 to 2009
$1.5M
Howard Hughes Medical InstituteNCI NIH HHS CA111506NCI NIH HHS CA78378NCI NIH HHS P01 CA078378NCI NIH HHS R01 CA111506NCI NIH HHS R01 CA143083NIAID NIH HHS AI29530NIAID NIH HHS P01 AI029530NIAID NIH HHS U19 AI029530
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Angiogenesis InhibitorsAnimalsCancer VaccinesHumansImmunotherapyNeoplasmsNeovascularization, PathologicAngiogenesis InhibitorsCancer Vaccines

Identifiers

PMID21860259
PMCPMC3225770
OpenAlexW2083375727

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.